bioAffinity Technologies, Inc. Common Stock

BIAF

bioAffinity Technologies, Inc. (BIAF) is a biotechnology company focused on developing innovative diagnostic and therapeutic products utilizing proprietary bioinformatics and biomarker discovery platforms. The company's technologies aim to improve cancer detection, treatment, and personalized medicine approaches.

$1.35 -0.01 (-0.74%)
🚫 bioAffinity Technologies, Inc. Common Stock does not pay dividends

Company News

12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga • Benzinga Staff Writer • September 26, 2025

Multiple healthcare stocks experienced significant pre-market price movements, with some companies seeing notable gains while others faced declines.

Why Mesoblast Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Benzinga • Avi Kapoor • March 11, 2024

Shares of Mesoblast Limited (NASDAQ: MESO) rose sharply during Monday’s session after the company announced FDA support of an accelerated approval pathway for rexlemestrocel-L in end-stage heart failure patients. Mesoblast shares jumped 13.4% to $2.4399 on Monday. Here are some other stocks moving in today's mid-day session. Gainers Kidpik Co...

Nasdaq Gains 100 Points; Campbell Soup Earnings Top Views
Benzinga • Avi Kapoor • March 6, 2024

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 100 points on Wednesday. The Dow traded up 0.20% to 38,662.69 while the NASDAQ rose 0.64% to 16,041.08. The S&P 500 also rose, gaining, 0.53% to 5,105.72. Check This Out: Emerson Electric To Rally More Than 19%? Here Are 10 Top Analyst Forecasts For Wed...

Why United Natural Foods Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Benzinga • Avi Kapoor • March 6, 2024

Shares of United Natural Foods, Inc. (NYSE: UNFI) fell sharply during Wednesday’s session following second-quarter results. United Natural Foods posted adjusted earnings of 7 cents per share, compared to market estimates for a loss of 1 cent per share. The company’s quarterly sales came in at $7.78 billion, versus expectations of $7.87 billi...

Why SOPHiA GENETICS Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Benzinga • Avi Kapoor • March 5, 2024

Shares of SOPHiA GENETICS SA (NASDAQ: SOPH) fell sharply during Tuesday’s session after the company reported worse than expected fourth-quarter earnings and issued 2024 guidance. Sophia Genetics posted GAAP loss of 37 cents per share, versus market expectations for a loss of 27 cents per share. The company’s quarterly sales came in at $17.05...

Related Companies